ATE443717T1 - Metastin derivate und ihre verwendung - Google Patents

Metastin derivate und ihre verwendung

Info

Publication number
ATE443717T1
ATE443717T1 AT04700164T AT04700164T ATE443717T1 AT E443717 T1 ATE443717 T1 AT E443717T1 AT 04700164 T AT04700164 T AT 04700164T AT 04700164 T AT04700164 T AT 04700164T AT E443717 T1 ATE443717 T1 AT E443717T1
Authority
AT
Austria
Prior art keywords
metastin derivatives
derivatives
relates
suppressing activity
metastin
Prior art date
Application number
AT04700164T
Other languages
English (en)
Inventor
Nobutaka Fujii
Ryuichiro Doi
Shinya Oishi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE443717T1 publication Critical patent/ATE443717T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04700164T 2003-01-06 2004-01-05 Metastin derivate und ihre verwendung ATE443717T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/337,105 US6800611B2 (en) 2003-01-06 2003-01-06 Metastin derivatives and their use
PCT/IB2004/000606 WO2004060264A2 (en) 2003-01-06 2004-01-05 Metastin derivatives and their use

Publications (1)

Publication Number Publication Date
ATE443717T1 true ATE443717T1 (de) 2009-10-15

Family

ID=32710947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04700164T ATE443717T1 (de) 2003-01-06 2004-01-05 Metastin derivate und ihre verwendung

Country Status (8)

Country Link
US (1) US6800611B2 (de)
EP (1) EP1581557B1 (de)
JP (1) JP4335910B2 (de)
CN (1) CN1756765A (de)
AT (1) ATE443717T1 (de)
CA (1) CA2512553A1 (de)
DE (1) DE602004023271D1 (de)
WO (1) WO2004060264A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063221A1 (ja) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited メタスチン誘導体およびその用途
US7754220B2 (en) 2003-03-12 2010-07-13 Takeda Pharmaceutical Company Limited Methods of inhibiting secretion of follicle-stimulating hormone and testosterone
WO2006001499A2 (en) 2004-06-25 2006-01-05 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
UA97236C2 (en) * 2005-12-22 2012-01-25 Такеда Фармасьютикал Компани Лимитед Metastin derivatives and use thereof
AR058584A1 (es) * 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
US8404643B2 (en) * 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JP5279021B2 (ja) * 2006-04-26 2013-09-04 国立大学法人京都大学 Gpr54アゴニスト活性を有する新規化合物
UA94774C2 (en) * 2006-10-25 2011-06-10 Такеда Фармасьютикал Компани Лимитед Metastin derivatives and use thereof
JO3048B1 (ar) * 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
GB0719592D0 (en) 2007-10-08 2007-11-14 Medical Res Council Compound, use and method
US20110118172A1 (en) * 2008-04-24 2011-05-19 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
EP2275433B1 (de) * 2008-04-30 2017-06-07 Kyoto University Metastinderivat und verwendung davon
WO2010013762A1 (ja) 2008-07-30 2010-02-04 武田薬品工業株式会社 メタスチン誘導体およびその用途
EP2350118B1 (de) 2008-09-19 2016-03-30 Nektar Therapeutics Kohlenhydratbasisierte polymere zur wirkstoffabgabe und konjugate davon
EP2340047A1 (de) * 2008-09-19 2011-07-06 Nektar Therapeutics Polymerkonjugate von kiss1-peptiden
GEP20146001B (en) * 2008-12-29 2014-01-10 Takeda Pharmaceuticals Co Cancer prophylactic/therapeutic agent
US8716228B2 (en) 2009-05-27 2014-05-06 Yeda Research And Development Co. Ltd. GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
WO2013136338A1 (en) 2012-03-14 2013-09-19 Yeda Research And Development Co. Ltd At The Weizmann Institute Of Science Modified kisspeptin peptides and uses thereof
US20180116849A1 (en) * 2015-04-23 2018-05-03 Obalon Therapeutics, Inc. Systems and methods for determining failure of intragastric devices
CN116813705A (zh) 2017-07-05 2023-09-29 凯惠科技发展(上海)有限公司 一种肽类化合物、其应用及含其的组合物
WO2025217074A1 (en) 2024-04-08 2025-10-16 Radionetics Oncology, Inc. Kisspeptin receptor (kiss1r) targeted therapeutics and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4486187B2 (ja) 1998-10-27 2010-06-23 武田薬品工業株式会社 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド
WO2001075104A1 (fr) 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Nouvelle proteine, adn codant pour celle-ci, et son procede de production
WO2002085399A1 (fr) 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Preparations contenant un peptide
WO2004063221A1 (ja) * 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited メタスチン誘導体およびその用途

Also Published As

Publication number Publication date
US6800611B2 (en) 2004-10-05
WO2004060264A2 (en) 2004-07-22
JP4335910B2 (ja) 2009-09-30
US20040142875A1 (en) 2004-07-22
CN1756765A (zh) 2006-04-05
EP1581557B1 (de) 2009-09-23
CA2512553A1 (en) 2004-07-22
EP1581557A2 (de) 2005-10-05
DE602004023271D1 (de) 2009-11-05
WO2004060264A3 (en) 2004-12-02
JP2006517922A (ja) 2006-08-03

Similar Documents

Publication Publication Date Title
DE602004023271D1 (de) Metastin derivate und ihre verwendung
SG132672A1 (en) 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
CY1113538T1 (el) Παραγωγα της 5-αμινο-2,4,7-τριοξο-3,4,7,8-τετραϋδρο-2η-πυριδο[2,3-d] πυριμιδινης και παρομοιες ενωσεις για την αγωγη του καρκινου
CY1111069T1 (el) Παραγωγα διυδροπυραζολοπυριμιδινονης
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
CY1123919T1 (el) 1η-βενζιμιδαζολο-4-καρβοξαμιδια υποκατεστημενα με τεταρτοταγη ανθρακα στην 2-θεση ειναι ισχυροι αναστολεις parp
EA201171454A1 (ru) N-(ГЕТЕРО)АРИЛПИРРОЛИДИНОВЫЕ ПРОИЗВОДНЫЕ ПИРАЗОЛ-4-ИЛПИРРОЛО[2,3-d]ПИРИМИДИНОВ И ПИРРОЛ-3-ИЛПИРРОЛО[2,3-d]ПИРИМИДИНОВ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ
TW200610531A (en) Phthalazine derivatives as PARP inhibitors
TW200612950A (en) Quinazolinedione derivatives as PARP inhibitors
UA96565C2 (ru) Пиридильные ингибиторы хеджхоговской передачи сигнала
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
CY1113266T1 (el) Παραγωγο αρυλαμιδινης, αλας αυτου και αντιμυκητιασικο περιεχον αυτα
MA32505B1 (fr) 5-alcynyl-pyrimidines
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
EA201170344A1 (ru) Азаиндольные ингибиторы iap
NO20044526L (no) Hemisterlinderivater og anvendelser derav
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
ATE516270T1 (de) Neue derivate von psammaplin a, verfahren zu ihrer synthese und ihre verwendung für die vorbeugung oder behandlung von krebs
ATE445593T1 (de) Acetylenderivate
DE602006005084D1 (de) Verfahren zur vorhersage und verhinderung der resistenz gegen taxoid-verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties